banner
Proteasome inhibitor MLN2238, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ700

Proteasome inhibitor MLN2238, Purity ≥98%

Synonym: 1072833-77-2; Proteasome inhibitor; MLN 2238; MLN-2238

  • MDL: MFCD18251438
  • CAS Number: 1072833-77-2
  • Compound CID: 25183872
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MLN2238, soluble in DMSO and ethanol and insoluble in water, interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma. It targets 20S proteasome and 20S proteasome.
Molecular Weight
361
Molecular Formula
C14H19BCl2N2O4
Targets
20S proteasome: 0.93 nM (Ki); 20S proteasome: 3.4 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 64 mg/mL (177.26 mM); Water: Insoluble; Ethanol: 8 mg/mL (22.15 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
MLN2238 is utilized to investigate and inhibit proteasomes, which play a crucial role in degrading ubiquitinated proteins, and are involved in cancer research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0